Literature DB >> 8288599

Expression cloning and characterization of the hamster ileal sodium-dependent bile acid transporter.

M H Wong1, P Oelkers, A L Craddock, P A Dawson.   

Abstract

Active uptake of bile acids from the lumen of the small intestine is mediated by an ileal Na(+)-dependent bile acid transport system. To identify components of this transport system, an expression cloning strategy was employed to isolate a hamster ileal cDNA that exhibits bile acid transport activity. By Northern blot analysis, mRNA for the cloned transporter was readily detected in ileum and kidney but was absent from liver and proximal small intestine. The transporter cDNA encoded a 348-amino acid protein with seven potential transmembrane domains and three possible N-linked glycosylation sites. The amino acid sequence was 35% identical and 63% similar to the rat liver Na+/bile acid cotransporter. After transfection into COS cells, the hamster cDNA transported taurocholate in a strict Na(+)-dependent fashion with an apparent Km of 33 microM. This taurocholate transport was inhibited by various bile acids but not by taurine or other organic anions. The Na+ dependence, saturability, and bile acid specificity of transport as well as the tissue specificity of mRNA expression strongly argue that the transporter cDNA characterized in this study is the Na+/bile acid cotransporter described previously in ileum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8288599

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Do steroids ameliorate bile acid malabsorption in Crohn's disease?

Authors:  R S Kwon; M C Carey
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

3.  [Metabolic long-term complications after urinary diversion].

Authors:  R Stein; C Ziesel; S Frees; J W Thüroff
Journal:  Urologe A       Date:  2012-04       Impact factor: 0.639

Review 4.  Advanced pharmacokinetic models based on organ clearance, circulatory, and fractal concepts.

Authors:  K Sandy Pang; Michael Weiss; Panos Macheras
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

5.  Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains.

Authors:  Antara Banerjee; Peter W Swaan
Journal:  Biochemistry       Date:  2006-01-24       Impact factor: 3.162

6.  Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.

Authors:  Pablo M González; Carlos F Lagos; Weslyn C Ward; James E Polli
Journal:  Mol Pharm       Date:  2013-12-26       Impact factor: 4.939

Review 7.  The Farnesoid X Receptor (FXR) as modulator of bile acid metabolism.

Authors:  Folkert Kuipers; Thierry Claudel; Ekkehard Sturm; Bart Staels
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

8.  Identification of genes encoding conjugated bile salt hydrolase and transport in Lactobacillus johnsonii 100-100.

Authors:  C A Elkins; D C Savage
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

Review 9.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

10.  Transport of bile acids in multidrug-resistance-protein 3-overexpressing cells co-transfected with the ileal Na+-dependent bile-acid transporter.

Authors:  Noam Zelcer; Tohru Saeki; Ilse Bot; Annemieke Kuil; Piet Borst
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.